Vaxform LLC

Bethlehem, PA

UEI
L2PLXD4EA569
CAGE
63X74
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Limited Liability Company
Entity structure
Partnership or Limited Liability Partnership
SAM.gov registration date
Physical address
Ben Franklin Techventures, 116 Research Dr, Bethlehem, PA 18015, USA
Website
vaxform.com
Founded
2010
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Award Agency Obligated Awarded
IND enabling studies for a group a strep vaccine 75N93021C00037 National Institute of Allergy and Infectious Diseases (NIH) $300,000
Sttr phase i - A12A-027-0056 W81XWH12C0183 Medical Command (Army) $849,505

Grant awards

Award Agency Obligated Awarded
Sbir phase i: development of an oral recombinant subunit vaccine to protect against covid-19 2031281 Division of Industrial Innovation $256,000
Sbir phase i: incorporation of a new adjuvant system to produce a thermally stable, orally administered… 1843518 Division of Industrial Innovation $225,000

Quick answers

Is Vaxform LLC registered in SAM.gov?

Yes. Vaxform LLC's SAM.gov registration is active through January 21, 2027.

What is Vaxform LLC's most recent federal award?

Vaxform LLC's most recent federal contract award is IND enabling studies for a group a strep vaccine (75N93021C00037), from National Institute of Allergy and Infectious Diseases (NIH), on August 1, 2021.

On GovTribe

See Vaxform LLC's full federal record

  • Federal contract awards
  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login